nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—SLC22A2—Estradiol—osteoporosis	0.0732	0.105	CbGbCtD
Propranolol—CYP1A1—Cholecalciferol—osteoporosis	0.0619	0.0884	CbGbCtD
Propranolol—CYP1A2—Estropipate—osteoporosis	0.0537	0.0767	CbGbCtD
Propranolol—CYP1A1—Estradiol—osteoporosis	0.0499	0.0713	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0399	0.057	CbGbCtD
Propranolol—CYP3A7—Estradiol—osteoporosis	0.0399	0.057	CbGbCtD
Propranolol—ABCB1—Ethinyl Estradiol—osteoporosis	0.0302	0.0432	CbGbCtD
Propranolol—CYP2C19—Cholecalciferol—osteoporosis	0.03	0.0428	CbGbCtD
Propranolol—CYP3A5—Estradiol—osteoporosis	0.0299	0.0428	CbGbCtD
Propranolol—CYP3A4—Estropipate—osteoporosis	0.0281	0.0402	CbGbCtD
Propranolol—CYP3A4—Calcitriol—osteoporosis	0.0281	0.0402	CbGbCtD
Propranolol—CYP1A2—Conjugated Estrogens—osteoporosis	0.0254	0.0363	CbGbCtD
Propranolol—CYP2C19—Estradiol—osteoporosis	0.0242	0.0345	CbGbCtD
Propranolol—CYP2D6—Cholecalciferol—osteoporosis	0.0228	0.0325	CbGbCtD
Propranolol—CYP3A4—Ergocalciferol—osteoporosis	0.0225	0.0321	CbGbCtD
Propranolol—CYP1A2—Estradiol—osteoporosis	0.0223	0.0318	CbGbCtD
Propranolol—ABCB1—Conjugated Estrogens—osteoporosis	0.0222	0.0317	CbGbCtD
Propranolol—ABCB1—Estradiol—osteoporosis	0.0195	0.0278	CbGbCtD
Propranolol—CYP3A4—Raloxifene—osteoporosis	0.0188	0.0268	CbGbCtD
Propranolol—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0181	0.0259	CbGbCtD
Propranolol—CYP3A4—Cholecalciferol—osteoporosis	0.0145	0.0207	CbGbCtD
Propranolol—CYP3A4—Conjugated Estrogens—osteoporosis	0.0133	0.019	CbGbCtD
Propranolol—CYP3A4—Estradiol—osteoporosis	0.0117	0.0167	CbGbCtD
Propranolol—Cough—Risedronate—osteoporosis	0.000459	0.00184	CcSEcCtD
Propranolol—Dyspepsia—Ibandronate—osteoporosis	0.000458	0.00183	CcSEcCtD
Propranolol—Pain—Alendronate—osteoporosis	0.000457	0.00183	CcSEcCtD
Propranolol—Constipation—Alendronate—osteoporosis	0.000457	0.00183	CcSEcCtD
Propranolol—Erythema—Zoledronate—osteoporosis	0.000456	0.00183	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000456	0.00183	CcSEcCtD
Propranolol—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000454	0.00182	CcSEcCtD
Propranolol—Somnolence—Calcitriol—osteoporosis	0.000453	0.00181	CcSEcCtD
Propranolol—Decreased appetite—Ibandronate—osteoporosis	0.000452	0.00181	CcSEcCtD
Propranolol—Infestation NOS—Estradiol—osteoporosis	0.00045	0.0018	CcSEcCtD
Propranolol—Infestation—Estradiol—osteoporosis	0.00045	0.0018	CcSEcCtD
Propranolol—Pain—Raloxifene—osteoporosis	0.00045	0.0018	CcSEcCtD
Propranolol—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000449	0.0018	CcSEcCtD
Propranolol—Depression—Estradiol—osteoporosis	0.000449	0.0018	CcSEcCtD
Propranolol—Fatigue—Ibandronate—osteoporosis	0.000449	0.0018	CcSEcCtD
Propranolol—Alopecia—Conjugated Estrogens—osteoporosis	0.000446	0.00179	CcSEcCtD
Propranolol—Pain—Ibandronate—osteoporosis	0.000445	0.00178	CcSEcCtD
Propranolol—Constipation—Ibandronate—osteoporosis	0.000445	0.00178	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000444	0.00178	CcSEcCtD
Propranolol—Gastrointestinal pain—Estropipate—osteoporosis	0.000444	0.00178	CcSEcCtD
Propranolol—Decreased appetite—Calcitriol—osteoporosis	0.000443	0.00177	CcSEcCtD
Propranolol—Mental disorder—Conjugated Estrogens—osteoporosis	0.000442	0.00177	CcSEcCtD
Propranolol—Erythema—Conjugated Estrogens—osteoporosis	0.000439	0.00176	CcSEcCtD
Propranolol—Gastrointestinal pain—Alendronate—osteoporosis	0.000437	0.00175	CcSEcCtD
Propranolol—Infection—Ethinyl Estradiol—osteoporosis	0.000437	0.00175	CcSEcCtD
Propranolol—Cough—Pamidronate—osteoporosis	0.000436	0.00175	CcSEcCtD
Propranolol—Constipation—Calcitriol—osteoporosis	0.000436	0.00174	CcSEcCtD
Propranolol—Pain—Calcitriol—osteoporosis	0.000436	0.00174	CcSEcCtD
Propranolol—Convulsion—Pamidronate—osteoporosis	0.000433	0.00173	CcSEcCtD
Propranolol—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000431	0.00173	CcSEcCtD
Propranolol—Urticaria—Estropipate—osteoporosis	0.000431	0.00173	CcSEcCtD
Propranolol—Gastrointestinal pain—Raloxifene—osteoporosis	0.00043	0.00172	CcSEcCtD
Propranolol—Diarrhoea—Etidronic acid—osteoporosis	0.000429	0.00172	CcSEcCtD
Propranolol—Abdominal pain—Estropipate—osteoporosis	0.000429	0.00172	CcSEcCtD
Propranolol—Body temperature increased—Estropipate—osteoporosis	0.000429	0.00172	CcSEcCtD
Propranolol—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000427	0.00171	CcSEcCtD
Propranolol—Infection—Risedronate—osteoporosis	0.000426	0.00171	CcSEcCtD
Propranolol—Gastrointestinal pain—Ibandronate—osteoporosis	0.000426	0.0017	CcSEcCtD
Propranolol—Urticaria—Alendronate—osteoporosis	0.000425	0.0017	CcSEcCtD
Propranolol—Abdominal pain—Alendronate—osteoporosis	0.000423	0.00169	CcSEcCtD
Propranolol—Body temperature increased—Alendronate—osteoporosis	0.000423	0.00169	CcSEcCtD
Propranolol—Nervous system disorder—Risedronate—osteoporosis	0.000421	0.00168	CcSEcCtD
Propranolol—Agitation—Zoledronate—osteoporosis	0.000419	0.00168	CcSEcCtD
Propranolol—Skin disorder—Risedronate—osteoporosis	0.000417	0.00167	CcSEcCtD
Propranolol—Gastrointestinal pain—Calcitriol—osteoporosis	0.000417	0.00167	CcSEcCtD
Propranolol—Body temperature increased—Raloxifene—osteoporosis	0.000416	0.00166	CcSEcCtD
Propranolol—Abdominal pain—Raloxifene—osteoporosis	0.000416	0.00166	CcSEcCtD
Propranolol—Urticaria—Ibandronate—osteoporosis	0.000413	0.00166	CcSEcCtD
Propranolol—Abdominal pain—Ibandronate—osteoporosis	0.000411	0.00165	CcSEcCtD
Propranolol—Body temperature increased—Ibandronate—osteoporosis	0.000411	0.00165	CcSEcCtD
Propranolol—Vertigo—Zoledronate—osteoporosis	0.00041	0.00164	CcSEcCtD
Propranolol—Anaphylactic shock—Pamidronate—osteoporosis	0.000408	0.00163	CcSEcCtD
Propranolol—Infection—Pamidronate—osteoporosis	0.000405	0.00162	CcSEcCtD
Propranolol—Urticaria—Calcitriol—osteoporosis	0.000405	0.00162	CcSEcCtD
Propranolol—Body temperature increased—Calcitriol—osteoporosis	0.000403	0.00161	CcSEcCtD
Propranolol—Abdominal pain—Calcitriol—osteoporosis	0.000403	0.00161	CcSEcCtD
Propranolol—Pharyngitis—Estradiol—osteoporosis	0.000401	0.00161	CcSEcCtD
Propranolol—Hypersensitivity—Estropipate—osteoporosis	0.0004	0.0016	CcSEcCtD
Propranolol—Nervous system disorder—Pamidronate—osteoporosis	0.0004	0.0016	CcSEcCtD
Propranolol—Vomiting—Etidronic acid—osteoporosis	0.000399	0.0016	CcSEcCtD
Propranolol—Cough—Zoledronate—osteoporosis	0.000398	0.00159	CcSEcCtD
Propranolol—Rash—Etidronic acid—osteoporosis	0.000396	0.00158	CcSEcCtD
Propranolol—Convulsion—Zoledronate—osteoporosis	0.000395	0.00158	CcSEcCtD
Propranolol—Dermatitis—Etidronic acid—osteoporosis	0.000395	0.00158	CcSEcCtD
Propranolol—Vertigo—Conjugated Estrogens—osteoporosis	0.000395	0.00158	CcSEcCtD
Propranolol—Hypersensitivity—Alendronate—osteoporosis	0.000394	0.00158	CcSEcCtD
Propranolol—Asthenia—Estropipate—osteoporosis	0.000389	0.00156	CcSEcCtD
Propranolol—Visual impairment—Estradiol—osteoporosis	0.000389	0.00156	CcSEcCtD
Propranolol—Insomnia—Risedronate—osteoporosis	0.000388	0.00155	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000386	0.00155	CcSEcCtD
Propranolol—Paraesthesia—Risedronate—osteoporosis	0.000385	0.00154	CcSEcCtD
Propranolol—Asthenia—Alendronate—osteoporosis	0.000384	0.00154	CcSEcCtD
Propranolol—Hypersensitivity—Ibandronate—osteoporosis	0.000383	0.00154	CcSEcCtD
Propranolol—Cough—Conjugated Estrogens—osteoporosis	0.000383	0.00154	CcSEcCtD
Propranolol—Dyspnoea—Risedronate—osteoporosis	0.000382	0.00153	CcSEcCtD
Propranolol—Erythema multiforme—Estradiol—osteoporosis	0.000382	0.00153	CcSEcCtD
Propranolol—Convulsion—Conjugated Estrogens—osteoporosis	0.000381	0.00152	CcSEcCtD
Propranolol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00038	0.00152	CcSEcCtD
Propranolol—Fatigue—Ethinyl Estradiol—osteoporosis	0.000379	0.00152	CcSEcCtD
Propranolol—Dyspepsia—Risedronate—osteoporosis	0.000378	0.00151	CcSEcCtD
Propranolol—Constipation—Ethinyl Estradiol—osteoporosis	0.000376	0.00151	CcSEcCtD
Propranolol—Hypersensitivity—Calcitriol—osteoporosis	0.000375	0.0015	CcSEcCtD
Propranolol—Cardiac disorder—Estradiol—osteoporosis	0.000375	0.0015	CcSEcCtD
Propranolol—Asthenia—Ibandronate—osteoporosis	0.000373	0.0015	CcSEcCtD
Propranolol—Nausea—Etidronic acid—osteoporosis	0.000373	0.00149	CcSEcCtD
Propranolol—Anaphylactic shock—Zoledronate—osteoporosis	0.000372	0.00149	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000372	0.00149	CcSEcCtD
Propranolol—Diarrhoea—Estropipate—osteoporosis	0.000371	0.00149	CcSEcCtD
Propranolol—Gastrointestinal disorder—Risedronate—osteoporosis	0.00037	0.00148	CcSEcCtD
Propranolol—Infection—Zoledronate—osteoporosis	0.00037	0.00148	CcSEcCtD
Propranolol—Fatigue—Risedronate—osteoporosis	0.00037	0.00148	CcSEcCtD
Propranolol—Insomnia—Pamidronate—osteoporosis	0.000369	0.00148	CcSEcCtD
Propranolol—Pain—Risedronate—osteoporosis	0.000367	0.00147	CcSEcCtD
Propranolol—Constipation—Risedronate—osteoporosis	0.000367	0.00147	CcSEcCtD
Propranolol—Paraesthesia—Pamidronate—osteoporosis	0.000366	0.00147	CcSEcCtD
Propranolol—Diarrhoea—Alendronate—osteoporosis	0.000366	0.00146	CcSEcCtD
Propranolol—Asthenia—Calcitriol—osteoporosis	0.000366	0.00146	CcSEcCtD
Propranolol—Nervous system disorder—Zoledronate—osteoporosis	0.000365	0.00146	CcSEcCtD
Propranolol—Dyspnoea—Pamidronate—osteoporosis	0.000364	0.00146	CcSEcCtD
Propranolol—Somnolence—Pamidronate—osteoporosis	0.000362	0.00145	CcSEcCtD
Propranolol—Skin disorder—Zoledronate—osteoporosis	0.000362	0.00145	CcSEcCtD
Propranolol—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00036	0.00144	CcSEcCtD
Propranolol—Diarrhoea—Raloxifene—osteoporosis	0.00036	0.00144	CcSEcCtD
Propranolol—Dyspepsia—Pamidronate—osteoporosis	0.000359	0.00144	CcSEcCtD
Propranolol—Dizziness—Estropipate—osteoporosis	0.000359	0.00144	CcSEcCtD
Propranolol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000359	0.00144	CcSEcCtD
Propranolol—Alopecia—Estradiol—osteoporosis	0.000357	0.00143	CcSEcCtD
Propranolol—Infection—Conjugated Estrogens—osteoporosis	0.000356	0.00143	CcSEcCtD
Propranolol—Diarrhoea—Ibandronate—osteoporosis	0.000356	0.00143	CcSEcCtD
Propranolol—Decreased appetite—Pamidronate—osteoporosis	0.000354	0.00142	CcSEcCtD
Propranolol—Mental disorder—Estradiol—osteoporosis	0.000354	0.00142	CcSEcCtD
Propranolol—Dizziness—Alendronate—osteoporosis	0.000354	0.00142	CcSEcCtD
Propranolol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000352	0.00141	CcSEcCtD
Propranolol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000352	0.00141	CcSEcCtD
Propranolol—Erythema—Estradiol—osteoporosis	0.000352	0.00141	CcSEcCtD
Propranolol—Fatigue—Pamidronate—osteoporosis	0.000352	0.00141	CcSEcCtD
Propranolol—Gastrointestinal pain—Risedronate—osteoporosis	0.000351	0.0014	CcSEcCtD
Propranolol—Urticaria—Ethinyl Estradiol—osteoporosis	0.000349	0.0014	CcSEcCtD
Propranolol—Pain—Pamidronate—osteoporosis	0.000349	0.0014	CcSEcCtD
Propranolol—Constipation—Pamidronate—osteoporosis	0.000349	0.0014	CcSEcCtD
Propranolol—Diarrhoea—Calcitriol—osteoporosis	0.000349	0.0014	CcSEcCtD
Propranolol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000348	0.00139	CcSEcCtD
Propranolol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000348	0.00139	CcSEcCtD
Propranolol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000348	0.00139	CcSEcCtD
Propranolol—Dizziness—Raloxifene—osteoporosis	0.000348	0.00139	CcSEcCtD
Propranolol—Vomiting—Estropipate—osteoporosis	0.000345	0.00138	CcSEcCtD
Propranolol—Dizziness—Ibandronate—osteoporosis	0.000344	0.00138	CcSEcCtD
Propranolol—Rash—Estropipate—osteoporosis	0.000342	0.00137	CcSEcCtD
Propranolol—Dermatitis—Estropipate—osteoporosis	0.000342	0.00137	CcSEcCtD
Propranolol—Urticaria—Risedronate—osteoporosis	0.000341	0.00136	CcSEcCtD
Propranolol—Vomiting—Alendronate—osteoporosis	0.00034	0.00136	CcSEcCtD
Propranolol—Abdominal pain—Risedronate—osteoporosis	0.000339	0.00136	CcSEcCtD
Propranolol—Body temperature increased—Risedronate—osteoporosis	0.000339	0.00136	CcSEcCtD
Propranolol—Rash—Alendronate—osteoporosis	0.000337	0.00135	CcSEcCtD
Propranolol—Insomnia—Zoledronate—osteoporosis	0.000337	0.00135	CcSEcCtD
Propranolol—Dermatitis—Alendronate—osteoporosis	0.000337	0.00135	CcSEcCtD
Propranolol—Paraesthesia—Zoledronate—osteoporosis	0.000334	0.00134	CcSEcCtD
Propranolol—Vomiting—Raloxifene—osteoporosis	0.000334	0.00134	CcSEcCtD
Propranolol—Gastrointestinal pain—Pamidronate—osteoporosis	0.000333	0.00134	CcSEcCtD
Propranolol—Dyspnoea—Zoledronate—osteoporosis	0.000332	0.00133	CcSEcCtD
Propranolol—Rash—Raloxifene—osteoporosis	0.000331	0.00133	CcSEcCtD
Propranolol—Dermatitis—Raloxifene—osteoporosis	0.000331	0.00133	CcSEcCtD
Propranolol—Somnolence—Zoledronate—osteoporosis	0.000331	0.00133	CcSEcCtD
Propranolol—Vomiting—Ibandronate—osteoporosis	0.000331	0.00133	CcSEcCtD
Propranolol—Rash—Ibandronate—osteoporosis	0.000328	0.00131	CcSEcCtD
Propranolol—Dermatitis—Ibandronate—osteoporosis	0.000328	0.00131	CcSEcCtD
Propranolol—Dyspepsia—Zoledronate—osteoporosis	0.000328	0.00131	CcSEcCtD
Propranolol—Insomnia—Conjugated Estrogens—osteoporosis	0.000324	0.0013	CcSEcCtD
Propranolol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000324	0.0013	CcSEcCtD
Propranolol—Vomiting—Calcitriol—osteoporosis	0.000324	0.0013	CcSEcCtD
Propranolol—Decreased appetite—Zoledronate—osteoporosis	0.000324	0.0013	CcSEcCtD
Propranolol—Agitation—Estradiol—osteoporosis	0.000323	0.00129	CcSEcCtD
Propranolol—Nausea—Estropipate—osteoporosis	0.000322	0.00129	CcSEcCtD
Propranolol—Body temperature increased—Pamidronate—osteoporosis	0.000322	0.00129	CcSEcCtD
Propranolol—Abdominal pain—Pamidronate—osteoporosis	0.000322	0.00129	CcSEcCtD
Propranolol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000322	0.00129	CcSEcCtD
Propranolol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000322	0.00129	CcSEcCtD
Propranolol—Rash—Calcitriol—osteoporosis	0.000321	0.00129	CcSEcCtD
Propranolol—Fatigue—Zoledronate—osteoporosis	0.000321	0.00129	CcSEcCtD
Propranolol—Dermatitis—Calcitriol—osteoporosis	0.000321	0.00129	CcSEcCtD
Propranolol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00032	0.00128	CcSEcCtD
Propranolol—Somnolence—Conjugated Estrogens—osteoporosis	0.000319	0.00128	CcSEcCtD
Propranolol—Pain—Zoledronate—osteoporosis	0.000318	0.00128	CcSEcCtD
Propranolol—Constipation—Zoledronate—osteoporosis	0.000318	0.00128	CcSEcCtD
Propranolol—Nausea—Alendronate—osteoporosis	0.000318	0.00127	CcSEcCtD
Propranolol—Hypersensitivity—Risedronate—osteoporosis	0.000316	0.00127	CcSEcCtD
Propranolol—Vertigo—Estradiol—osteoporosis	0.000316	0.00127	CcSEcCtD
Propranolol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000316	0.00126	CcSEcCtD
Propranolol—Asthenia—Ethinyl Estradiol—osteoporosis	0.000316	0.00126	CcSEcCtD
Propranolol—Nausea—Raloxifene—osteoporosis	0.000312	0.00125	CcSEcCtD
Propranolol—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000312	0.00125	CcSEcCtD
Propranolol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00031	0.00124	CcSEcCtD
Propranolol—Fatigue—Conjugated Estrogens—osteoporosis	0.000309	0.00124	CcSEcCtD
Propranolol—Nausea—Ibandronate—osteoporosis	0.000309	0.00124	CcSEcCtD
Propranolol—Asthenia—Risedronate—osteoporosis	0.000308	0.00123	CcSEcCtD
Propranolol—Cough—Estradiol—osteoporosis	0.000307	0.00123	CcSEcCtD
Propranolol—Pain—Conjugated Estrogens—osteoporosis	0.000307	0.00123	CcSEcCtD
Propranolol—Constipation—Conjugated Estrogens—osteoporosis	0.000307	0.00123	CcSEcCtD
Propranolol—Gastrointestinal pain—Zoledronate—osteoporosis	0.000305	0.00122	CcSEcCtD
Propranolol—Nausea—Calcitriol—osteoporosis	0.000303	0.00121	CcSEcCtD
Propranolol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000301	0.00121	CcSEcCtD
Propranolol—Hypersensitivity—Pamidronate—osteoporosis	0.0003	0.0012	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000297	0.00119	CcSEcCtD
Propranolol—Urticaria—Zoledronate—osteoporosis	0.000296	0.00118	CcSEcCtD
Propranolol—Body temperature increased—Zoledronate—osteoporosis	0.000294	0.00118	CcSEcCtD
Propranolol—Abdominal pain—Zoledronate—osteoporosis	0.000294	0.00118	CcSEcCtD
Propranolol—Diarrhoea—Risedronate—osteoporosis	0.000293	0.00118	CcSEcCtD
Propranolol—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000293	0.00117	CcSEcCtD
Propranolol—Asthenia—Pamidronate—osteoporosis	0.000293	0.00117	CcSEcCtD
Propranolol—Dizziness—Ethinyl Estradiol—osteoporosis	0.000291	0.00116	CcSEcCtD
Propranolol—Anaphylactic shock—Estradiol—osteoporosis	0.000287	0.00115	CcSEcCtD
Propranolol—Infection—Estradiol—osteoporosis	0.000285	0.00114	CcSEcCtD
Propranolol—Urticaria—Conjugated Estrogens—osteoporosis	0.000285	0.00114	CcSEcCtD
Propranolol—Dizziness—Risedronate—osteoporosis	0.000284	0.00114	CcSEcCtD
Propranolol—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000284	0.00114	CcSEcCtD
Propranolol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000284	0.00114	CcSEcCtD
Propranolol—Nervous system disorder—Estradiol—osteoporosis	0.000281	0.00113	CcSEcCtD
Propranolol—Vomiting—Ethinyl Estradiol—osteoporosis	0.00028	0.00112	CcSEcCtD
Propranolol—Diarrhoea—Pamidronate—osteoporosis	0.000279	0.00112	CcSEcCtD
Propranolol—Skin disorder—Estradiol—osteoporosis	0.000279	0.00112	CcSEcCtD
Propranolol—Rash—Ethinyl Estradiol—osteoporosis	0.000277	0.00111	CcSEcCtD
Propranolol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000277	0.00111	CcSEcCtD
Propranolol—Hypersensitivity—Zoledronate—osteoporosis	0.000274	0.0011	CcSEcCtD
Propranolol—Vomiting—Risedronate—osteoporosis	0.000273	0.00109	CcSEcCtD
Propranolol—Rash—Risedronate—osteoporosis	0.00027	0.00108	CcSEcCtD
Propranolol—Dermatitis—Risedronate—osteoporosis	0.00027	0.00108	CcSEcCtD
Propranolol—Dizziness—Pamidronate—osteoporosis	0.00027	0.00108	CcSEcCtD
Propranolol—Asthenia—Zoledronate—osteoporosis	0.000267	0.00107	CcSEcCtD
Propranolol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000264	0.00106	CcSEcCtD
Propranolol—Nausea—Ethinyl Estradiol—osteoporosis	0.000261	0.00105	CcSEcCtD
Propranolol—Insomnia—Estradiol—osteoporosis	0.00026	0.00104	CcSEcCtD
Propranolol—Vomiting—Pamidronate—osteoporosis	0.000259	0.00104	CcSEcCtD
Propranolol—Paraesthesia—Estradiol—osteoporosis	0.000258	0.00103	CcSEcCtD
Propranolol—Asthenia—Conjugated Estrogens—osteoporosis	0.000257	0.00103	CcSEcCtD
Propranolol—Rash—Pamidronate—osteoporosis	0.000257	0.00103	CcSEcCtD
Propranolol—Dermatitis—Pamidronate—osteoporosis	0.000257	0.00103	CcSEcCtD
Propranolol—Dyspnoea—Estradiol—osteoporosis	0.000256	0.00102	CcSEcCtD
Propranolol—Somnolence—Estradiol—osteoporosis	0.000255	0.00102	CcSEcCtD
Propranolol—Diarrhoea—Zoledronate—osteoporosis	0.000255	0.00102	CcSEcCtD
Propranolol—Nausea—Risedronate—osteoporosis	0.000255	0.00102	CcSEcCtD
Propranolol—Dyspepsia—Estradiol—osteoporosis	0.000253	0.00101	CcSEcCtD
Propranolol—Decreased appetite—Estradiol—osteoporosis	0.00025	0.000999	CcSEcCtD
Propranolol—Gastrointestinal disorder—Estradiol—osteoporosis	0.000248	0.000992	CcSEcCtD
Propranolol—Fatigue—Estradiol—osteoporosis	0.000247	0.000991	CcSEcCtD
Propranolol—Dizziness—Zoledronate—osteoporosis	0.000246	0.000986	CcSEcCtD
Propranolol—Pain—Estradiol—osteoporosis	0.000245	0.000983	CcSEcCtD
Propranolol—Constipation—Estradiol—osteoporosis	0.000245	0.000983	CcSEcCtD
Propranolol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000245	0.000983	CcSEcCtD
Propranolol—Nausea—Pamidronate—osteoporosis	0.000242	0.00097	CcSEcCtD
Propranolol—Dizziness—Conjugated Estrogens—osteoporosis	0.000237	0.00095	CcSEcCtD
Propranolol—Vomiting—Zoledronate—osteoporosis	0.000237	0.000948	CcSEcCtD
Propranolol—Rash—Zoledronate—osteoporosis	0.000235	0.00094	CcSEcCtD
Propranolol—Gastrointestinal pain—Estradiol—osteoporosis	0.000235	0.00094	CcSEcCtD
Propranolol—Dermatitis—Zoledronate—osteoporosis	0.000235	0.00094	CcSEcCtD
Propranolol—Vomiting—Conjugated Estrogens—osteoporosis	0.000228	0.000913	CcSEcCtD
Propranolol—Urticaria—Estradiol—osteoporosis	0.000228	0.000913	CcSEcCtD
Propranolol—Body temperature increased—Estradiol—osteoporosis	0.000227	0.000909	CcSEcCtD
Propranolol—Abdominal pain—Estradiol—osteoporosis	0.000227	0.000909	CcSEcCtD
Propranolol—Rash—Conjugated Estrogens—osteoporosis	0.000226	0.000905	CcSEcCtD
Propranolol—Dermatitis—Conjugated Estrogens—osteoporosis	0.000226	0.000905	CcSEcCtD
Propranolol—Nausea—Zoledronate—osteoporosis	0.000221	0.000886	CcSEcCtD
Propranolol—Nausea—Conjugated Estrogens—osteoporosis	0.000213	0.000853	CcSEcCtD
Propranolol—Hypersensitivity—Estradiol—osteoporosis	0.000211	0.000847	CcSEcCtD
Propranolol—Terbinafine—CYP19A1—osteoporosis	0.000207	1	CrCbGaD
Propranolol—Asthenia—Estradiol—osteoporosis	0.000206	0.000825	CcSEcCtD
Propranolol—Diarrhoea—Estradiol—osteoporosis	0.000196	0.000786	CcSEcCtD
Propranolol—Dizziness—Estradiol—osteoporosis	0.00019	0.00076	CcSEcCtD
Propranolol—Vomiting—Estradiol—osteoporosis	0.000182	0.000731	CcSEcCtD
Propranolol—Rash—Estradiol—osteoporosis	0.000181	0.000725	CcSEcCtD
Propranolol—Dermatitis—Estradiol—osteoporosis	0.000181	0.000724	CcSEcCtD
Propranolol—Nausea—Estradiol—osteoporosis	0.00017	0.000683	CcSEcCtD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.22e-05	0.000444	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ATIC—osteoporosis	2.22e-05	0.000443	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PNP—osteoporosis	2.22e-05	0.000443	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ENO1—osteoporosis	2.22e-05	0.000443	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ENO1—osteoporosis	2.21e-05	0.000442	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.21e-05	0.000442	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—TPI1—osteoporosis	2.2e-05	0.00044	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—WNT1—osteoporosis	2.19e-05	0.000438	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—POMC—osteoporosis	2.19e-05	0.000437	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PSMA2—osteoporosis	2.18e-05	0.000436	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PSMA5—osteoporosis	2.18e-05	0.000436	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—FGA—osteoporosis	2.18e-05	0.000436	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PSMA2—osteoporosis	2.18e-05	0.000435	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PSMA5—osteoporosis	2.18e-05	0.000435	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MGLL—osteoporosis	2.17e-05	0.000433	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	2.15e-05	0.000429	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—WNT1—osteoporosis	2.14e-05	0.000428	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ADCY5—osteoporosis	2.14e-05	0.000427	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—FGA—osteoporosis	2.13e-05	0.000426	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	2.1e-05	0.00042	CbGpPWpGaD
Propranolol—CYP3A4—Biological oxidations—POMC—osteoporosis	2.09e-05	0.000418	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—FGA—osteoporosis	2.09e-05	0.000417	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—TPI1—osteoporosis	2.08e-05	0.000416	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—P4HB—osteoporosis	2.07e-05	0.000414	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SPP1—osteoporosis	2.07e-05	0.000413	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.06e-05	0.000411	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—KL—osteoporosis	2.04e-05	0.000407	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GAPDH—osteoporosis	2.03e-05	0.000406	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—BMP2—osteoporosis	2.03e-05	0.000405	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTHLH—osteoporosis	2.03e-05	0.000405	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—IDH2—osteoporosis	2e-05	0.0004	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—POMC—osteoporosis	1.99e-05	0.000397	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—FGB—osteoporosis	1.98e-05	0.000396	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—BMP2—osteoporosis	1.98e-05	0.000396	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTHLH—osteoporosis	1.98e-05	0.000396	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—RAP1A—osteoporosis	1.98e-05	0.000396	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PKM—osteoporosis	1.97e-05	0.000394	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—FDPS—osteoporosis	1.97e-05	0.000394	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—P4HB—osteoporosis	1.96e-05	0.000391	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—IDH2—osteoporosis	1.96e-05	0.000391	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—FGB—osteoporosis	1.94e-05	0.000388	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTHLH—osteoporosis	1.94e-05	0.000387	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—BMP2—osteoporosis	1.94e-05	0.000387	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL6R—osteoporosis	1.94e-05	0.000387	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GAPDH—osteoporosis	1.92e-05	0.000384	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PSMA2—osteoporosis	1.92e-05	0.000383	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PSMA5—osteoporosis	1.92e-05	0.000383	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—FGB—osteoporosis	1.9e-05	0.000379	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—OXCT1—osteoporosis	1.88e-05	0.000376	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CA2—osteoporosis	1.88e-05	0.000376	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.88e-05	0.000376	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PSMA2—osteoporosis	1.87e-05	0.000374	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PSMA5—osteoporosis	1.87e-05	0.000374	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—RAP1A—osteoporosis	1.87e-05	0.000374	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IRS2—osteoporosis	1.87e-05	0.000374	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PGLS—osteoporosis	1.87e-05	0.000374	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPD2—osteoporosis	1.87e-05	0.000374	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—IDH2—osteoporosis	1.84e-05	0.000368	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP27A1—osteoporosis	1.84e-05	0.000367	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MGLL—osteoporosis	1.84e-05	0.000367	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ACP5—osteoporosis	1.83e-05	0.000366	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PSMA2—osteoporosis	1.83e-05	0.000366	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PSMA5—osteoporosis	1.83e-05	0.000366	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—LEP—osteoporosis	1.83e-05	0.000366	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.81e-05	0.000362	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.81e-05	0.000361	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.8e-05	0.00036	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ACP5—osteoporosis	1.79e-05	0.000357	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CALCA—osteoporosis	1.79e-05	0.000357	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.77e-05	0.000354	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CYP19A1—osteoporosis	1.77e-05	0.000353	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ESR1—osteoporosis	1.75e-05	0.000349	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CALCA—osteoporosis	1.75e-05	0.000349	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—POMC—osteoporosis	1.74e-05	0.000348	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.73e-05	0.000346	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.73e-05	0.000346	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ATIC—osteoporosis	1.71e-05	0.000342	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PNP—osteoporosis	1.71e-05	0.000342	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CALCA—osteoporosis	1.71e-05	0.000341	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—TPI1—osteoporosis	1.7e-05	0.00034	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—POMC—osteoporosis	1.7e-05	0.00034	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ACP5—osteoporosis	1.69e-05	0.000337	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.69e-05	0.000337	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.68e-05	0.000336	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—POMC—osteoporosis	1.67e-05	0.000333	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—TPI1—osteoporosis	1.66e-05	0.000332	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IRS1—osteoporosis	1.63e-05	0.000326	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.63e-05	0.000326	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KL—osteoporosis	1.62e-05	0.000324	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—P4HB—osteoporosis	1.6e-05	0.00032	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ENO1—osteoporosis	1.6e-05	0.00032	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ADCY5—osteoporosis	1.59e-05	0.000318	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KL—osteoporosis	1.59e-05	0.000317	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—POMC—osteoporosis	1.58e-05	0.000316	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PSMA2—osteoporosis	1.58e-05	0.000315	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PSMA5—osteoporosis	1.58e-05	0.000315	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—POMC—osteoporosis	1.57e-05	0.000314	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GAPDH—osteoporosis	1.57e-05	0.000314	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TPI1—osteoporosis	1.57e-05	0.000313	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—P4HB—osteoporosis	1.56e-05	0.000312	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—IDH2—osteoporosis	1.56e-05	0.000312	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KL—osteoporosis	1.55e-05	0.00031	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—POMC—osteoporosis	1.55e-05	0.000309	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SPP1—osteoporosis	1.54e-05	0.000308	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6R—osteoporosis	1.54e-05	0.000308	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GAPDH—osteoporosis	1.54e-05	0.000307	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6R—osteoporosis	1.54e-05	0.000307	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—RAP1A—osteoporosis	1.53e-05	0.000306	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IGF1—osteoporosis	1.51e-05	0.000302	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ENO1—osteoporosis	1.51e-05	0.000302	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.51e-05	0.000302	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6R—osteoporosis	1.51e-05	0.000301	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—RAP1A—osteoporosis	1.5e-05	0.000299	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PSMA2—osteoporosis	1.49e-05	0.000298	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PSMA5—osteoporosis	1.49e-05	0.000298	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.48e-05	0.000295	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—P4HB—osteoporosis	1.47e-05	0.000294	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.47e-05	0.000293	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CA2—osteoporosis	1.45e-05	0.000291	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—OXCT1—osteoporosis	1.45e-05	0.000291	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ADCY5—osteoporosis	1.45e-05	0.000289	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GAPDH—osteoporosis	1.45e-05	0.000289	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ADCY5—osteoporosis	1.45e-05	0.000289	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GPX1—osteoporosis	1.44e-05	0.000288	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GPX1—osteoporosis	1.44e-05	0.000288	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ACP5—osteoporosis	1.43e-05	0.000285	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MGLL—osteoporosis	1.42e-05	0.000283	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.41e-05	0.000282	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—RAP1A—osteoporosis	1.41e-05	0.000281	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.4e-05	0.000279	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—LEP—osteoporosis	1.37e-05	0.000273	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.34e-05	0.000267	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—MTHFR—osteoporosis	1.33e-05	0.000266	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—MTHFR—osteoporosis	1.33e-05	0.000265	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TPI1—osteoporosis	1.33e-05	0.000265	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.3e-05	0.00026	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.28e-05	0.000256	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ADCY5—osteoporosis	1.27e-05	0.000254	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—P4HB—osteoporosis	1.25e-05	0.000249	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ADCY5—osteoporosis	1.24e-05	0.000248	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ENO1—osteoporosis	1.24e-05	0.000247	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SPP1—osteoporosis	1.23e-05	0.000245	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GAPDH—osteoporosis	1.23e-05	0.000245	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PSMA2—osteoporosis	1.22e-05	0.000244	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PSMA5—osteoporosis	1.22e-05	0.000244	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.22e-05	0.000243	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.21e-05	0.000243	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000242	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ENO1—osteoporosis	1.21e-05	0.000241	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—IDH2—osteoporosis	1.21e-05	0.000241	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SPP1—osteoporosis	1.2e-05	0.00024	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—RAP1A—osteoporosis	1.19e-05	0.000238	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PSMA5—osteoporosis	1.19e-05	0.000238	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PSMA2—osteoporosis	1.19e-05	0.000238	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.18e-05	0.000235	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—POMC—osteoporosis	1.17e-05	0.000234	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—IL6—osteoporosis	1.16e-05	0.000231	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.14e-05	0.000229	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ENO1—osteoporosis	1.14e-05	0.000228	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.13e-05	0.000226	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.13e-05	0.000225	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PSMA2—osteoporosis	1.12e-05	0.000224	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PSMA5—osteoporosis	1.12e-05	0.000224	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.11e-05	0.000222	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ACP5—osteoporosis	1.1e-05	0.00022	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—LEP—osteoporosis	1.09e-05	0.000217	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IRS2—osteoporosis	1.09e-05	0.000217	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—POMC—osteoporosis	1.06e-05	0.000213	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—LEP—osteoporosis	1.06e-05	0.000212	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—POMC—osteoporosis	1.06e-05	0.000212	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.06e-05	0.000212	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ADCY5—osteoporosis	1.05e-05	0.000209	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GPX1—osteoporosis	1.04e-05	0.000208	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.04e-05	0.000208	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—LEP—osteoporosis	1.04e-05	0.000208	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.04e-05	0.000207	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TPI1—osteoporosis	1.02e-05	0.000205	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ESR1—osteoporosis	1.02e-05	0.000203	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ESR1—osteoporosis	9.93e-06	0.000198	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP19A1—osteoporosis	9.9e-06	0.000198	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ADCY5—osteoporosis	9.88e-06	0.000197	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GPX1—osteoporosis	9.85e-06	0.000197	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IRS1—osteoporosis	9.7e-06	0.000194	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP19A1—osteoporosis	9.66e-06	0.000193	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ENO1—osteoporosis	9.65e-06	0.000193	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—P4HB—osteoporosis	9.64e-06	0.000192	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—MTHFR—osteoporosis	9.62e-06	0.000192	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PSMA2—osteoporosis	9.51e-06	0.00019	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PSMA5—osteoporosis	9.51e-06	0.00019	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IRS1—osteoporosis	9.49e-06	0.00019	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GAPDH—osteoporosis	9.46e-06	0.000189	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—POMC—osteoporosis	9.34e-06	0.000187	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IRS1—osteoporosis	9.28e-06	0.000185	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—RAP1A—osteoporosis	9.21e-06	0.000184	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—POMC—osteoporosis	9.14e-06	0.000183	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6R—osteoporosis	9.11e-06	0.000182	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.11e-06	0.000182	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MYC—osteoporosis	9.1e-06	0.000182	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—MTHFR—osteoporosis	9.09e-06	0.000182	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TGFB1—osteoporosis	9.07e-06	0.000181	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IGF1—osteoporosis	8.98e-06	0.000179	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—POMC—osteoporosis	8.93e-06	0.000178	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6R—osteoporosis	8.91e-06	0.000178	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IGF1—osteoporosis	8.79e-06	0.000176	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6R—osteoporosis	8.72e-06	0.000174	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL6—osteoporosis	8.63e-06	0.000172	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IGF1—osteoporosis	8.59e-06	0.000172	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ADCY5—osteoporosis	8.09e-06	0.000162	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GPX1—osteoporosis	8.06e-06	0.000161	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ADCY5—osteoporosis	7.89e-06	0.000158	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GPX1—osteoporosis	7.87e-06	0.000157	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.71e-06	0.000154	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—POMC—osteoporosis	7.7e-06	0.000154	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ENO1—osteoporosis	7.45e-06	0.000149	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ADCY5—osteoporosis	7.44e-06	0.000149	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MTHFR—osteoporosis	7.44e-06	0.000149	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPX1—osteoporosis	7.41e-06	0.000148	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PSMA5—osteoporosis	7.34e-06	0.000147	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PSMA2—osteoporosis	7.34e-06	0.000147	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—POMC—osteoporosis	7.27e-06	0.000145	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MTHFR—osteoporosis	7.26e-06	0.000145	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—osteoporosis	6.87e-06	0.000137	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MTHFR—osteoporosis	6.84e-06	0.000137	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—osteoporosis	6.84e-06	0.000137	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—osteoporosis	6.78e-06	0.000135	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TGFB1—osteoporosis	6.76e-06	0.000135	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—osteoporosis	6.72e-06	0.000134	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—osteoporosis	6.57e-06	0.000131	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ADCY5—osteoporosis	6.3e-06	0.000126	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPX1—osteoporosis	6.28e-06	0.000125	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.95e-06	0.000119	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—POMC—osteoporosis	5.95e-06	0.000119	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—POMC—osteoporosis	5.81e-06	0.000116	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MTHFR—osteoporosis	5.8e-06	0.000116	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—POMC—osteoporosis	5.47e-06	0.000109	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—osteoporosis	5.4e-06	0.000108	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TGFB1—osteoporosis	5.39e-06	0.000108	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—osteoporosis	5.28e-06	0.000106	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TGFB1—osteoporosis	5.27e-06	0.000105	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—osteoporosis	5.16e-06	0.000103	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.15e-06	0.000103	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—osteoporosis	5.1e-06	0.000102	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ADCY5—osteoporosis	4.86e-06	9.72e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPX1—osteoporosis	4.85e-06	9.68e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—POMC—osteoporosis	4.64e-06	9.26e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MTHFR—osteoporosis	4.47e-06	8.94e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—osteoporosis	4.06e-06	8.11e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—osteoporosis	3.97e-06	7.93e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—osteoporosis	3.88e-06	7.75e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—POMC—osteoporosis	3.58e-06	7.15e-05	CbGpPWpGaD
